Pasar al contenido principal

INVESTIGANDO EL ROL DE IMPDH2 EN LA CROMATINA DE CELULAS DE CANCER DE MAMA TRIPLE NEGATIVO DURANTE LA RESPUESTA AL DAÑO DEL ADN

PID2022-141740NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues

  • Kourtis, Savvas
  • Gañez-Zapater, Antoni
  • Elbæk, Camilla Reiter
  • Schmidt, Alisa
  • Ghose, Ritobrata
  • Coll-Manzano, Albert
  • Espinar, Lorena
  • Guirola, Maria
  • Pardo-Lorente, Natalia
  • Garcia-Cao, Marta
  • Pfeiffer, Matilda
  • Haynes, Samuel
  • Fontaine, Frédéric
  • Müller, André
  • Sdelci, Sara
Metabolic and epigenetic rewiring are hallmarks of cancer, with increasing evidence suggesting crosstalk between these processes. While previous studies have hinted at the role of metabolic enzymes in the nucleus, the extent and functional relevance of their nuclear localization remain unclear. In this study, we present a comprehensive chromatome proteomic analysis across cancer lineages and healthy samples, revealing that metabolic enzyme moonlighting on chromatin is widespread across various tissues and metabolic pathways. We show that the abundance of metabolic enzymes on chromatin is tissue-specific, with oxidative phosphorylation proteins notably depleted in lung cancer, suggesting a link between nuclear metabolism and cell identity. Further, we explore the dynamic chromatin association of one-carbon folate enzymes, demonstrating their involvement in DNA damage and repair processes. Finally, we asked whether restricting metabolic enzymes to specific subcellular compartments rewires the transcriptome, thereby decoupling the observed transcriptional changes from mere metabolite diffusion. Our findings propose and validate novel non-canonical nuclear roles for several metabolic enzymes, providing new insights into the functional relationship between metabolism and chromatin regulation. This study underscores the hypothesis that the nucleus is populated by metabolic enzymes, offering new avenues for understanding how nuclear metabolism impacts chromatin function and cancer progression., We acknowledge support from the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA program and to the EMBL partnership. A.S. acknowledges financial support of a fellowship from the Marie Sklodowska-Curie Doctoral Network NUCLEAR (grant agreement no. 101166838). M.P. acknowledges financial support of a fellowship from the “la Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/DI23/11990062. S.S. acknowledges financial support from the Spanish Ministry of Science and Innovation through the Plan Nacional (grant agreement no. PID2022-141740NB-I00), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 852343). R.G. acknowledges financial support of a Severo Ochoa predoctoral fellowship. N.P.L. acknowledges financial support of a fellowship from the Boehringer Foundation. We thank Queralt Tolosa Ramon for creating the illustrations for OXPHOS complexes in Fig. 2, which are subject to a CC BY-NC-SA (Attribution-NonCommercial-ShareAlike) 4.0 International license.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting

  • Schmidt, Alisa
  • Pfeiffer, Matilda
  • Sdelci, Sara
Certain metabolic enzymes localize to the nucleus, where they perform regulatory functions that extend far beyond canonical metabolism. Once inside, they influence chromatin organization, transcription, DNA repair, and cell cycle progression. This review summarizes recent advances that redefine metabolism as a nuclear process and reshape our understanding of metabolic regulation. It further defines the emerging hallmarks of nuclear metabolism and discusses how these insights open new avenues for cancer therapies., We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA program, and to the EMBL partnership. A.S. acknowledges financial support of a fellowship from the Marie Sklodowska-Curie Doctoral Network NUCLEAR (grant agreement no. 101166838). M.P. acknowledges financial support of a fellowship from the 'la Caixa' Foundation (ID 100010434). The fellowship code is LCF/BQ/DI23/11990062. S.S. acknowledges financial support from the Spanish Ministry of Science and Innovation through the Plan Nacional (grant agreement no. PID2022-141740NB-I00), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 852343).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity

  • Espinar, Lorena
  • Garcia-Cao, Marta
  • Schmidt, Alisa
  • Kourtis, Savvas
  • Gañez-Zapater, Antoni
  • Aranda Vallejo, Carla
  • Ghose, Ritobrata
  • García-López, Laura
  • Sheraj, Ilir
  • Pardo-Lorente, Natalia
  • Bantulà, Marina
  • Pascual-Reguant, Laura, 1990-
  • Darai, Evangelia
  • Guirola, Maria
  • Montero, Joan
  • Sdelci, Sara
Nuclear metabolism and DNA damage response are intertwined processes, but the precise molecular links remain elusive. Here, we explore this crosstalk using triple-negative breast cancer (TNBC) as a model, a subtype often prone to DNA damage accumulation. We show that the de novo purine synthesis enzyme IMPDH2 is enriched on chromatin in TNBC compared to other subtypes. IMPDH2 chromatin localization is DNA damage dependent, and IMPDH2 repression leads to DNA damage accumulation. On chromatin, IMPDH2 interacts with and modulates PARP1 activity by controlling the nuclear availability of NAD+ to fine-tune the DNA damage response. However, when IMPDH2 is restricted to the nucleus, it depletes nuclear NAD+, leading to PARP1 cleavage and cell death. Our study identifies a non-canonical nuclear role for IMPDH2, acting as a convergence point of nuclear metabolism and DNA damage response., The authors would like to thank the Genomics Unit at the CRG for assistance with the sequencing, the CRG Proteomics Facility (Barcelona, Spain) for the chromatome MS analysis, the CRG Flow Cytometry Facility (Barcelona, Spain) for the cell cycle analysis, Dr. Ivan Perez-Nuñez from Dr. Toni Celià-Terrassa group (IMIM, Barcelona, Spain) for helping with the IHC analysis. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech). We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA program. N.P.L. is supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. L.P.R. is supported by a Fundación Francisco Cobo (Eduardo Gallego) postdoctoral fellowship. The Sdelci lab’s contributions to this study have received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 852343), and from the Spanish Plan Estatal grants (Ministerio de Ciencia e Innovación, PID2019-110598GA-I00/AEI/10.13039/501100011033 and PID2022-141740NB-I00 funded by MICIU /AEI /10.13039/501100011033 / FEDER, UE) and from Fundación BBVA under Beca Leonardo a Investigadores y Creadores Culturales 2022 (LEO22-2-2290-BBM-BAS-167).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting

  • Schmidt, Alisa
  • Pfeiffer, Matilda
  • Sdelci, Sara
Certain metabolic enzymes localize to the nucleus, where they perform regulatory functions that extend far beyond canonical metabolism. Once inside, they influence chromatin organization, transcription, DNA repair, and cell cycle progression. This review summarizes recent advances that redefine metabolism as a nuclear process and reshape our understanding of metabolic regulation. It further defines the emerging hallmarks of nuclear metabolism and discusses how these insights open new avenues for cancer therapies., We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA program, and to the EMBL partnership. A.S. acknowledges financial support of a fellowship from the Marie Sklodowska-Curie Doctoral Network NUCLEAR (grant agreement no. 101166838). M.P. acknowledges financial support of a fellowship from the 'la Caixa' Foundation (ID 100010434). The fellowship code is LCF/BQ/DI23/11990062. S.S. acknowledges financial support from the Spanish Ministry of Science and Innovation through the Plan Nacional (grant agreement no. PID2022-141740NB-I00), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 852343).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity

  • Espinar, Lorena
  • Garcia-Cao, Marta
  • Schmidt, Alisa
  • Kourtis, Savvas
  • Gañez-Zapater, Antoni
  • Aranda Vallejo, Carla
  • Ghose, Ritobrata
  • García-López, Laura
  • Sheraj, Ilir
  • Pardo Lorente, Natalia
  • Bantulà, Marina
  • Pascual-Reguant, Laura, 1990-
  • Darai, Evangelia
  • Guirola, Maria
  • Montero, Joan
  • Sdelci, Sara
Nuclear metabolism and DNA damage response are intertwined processes, but the precise molecular links remain elusive. Here, we explore this crosstalk using triple-negative breast cancer (TNBC) as a model, a subtype often prone to DNA damage accumulation. We show that the de novo purine synthesis enzyme IMPDH2 is enriched on chromatin in TNBC compared to other subtypes. IMPDH2 chromatin localization is DNA damage dependent, and IMPDH2 repression leads to DNA damage accumulation. On chromatin, IMPDH2 interacts with and modulates PARP1 activity by controlling the nuclear availability of NAD+ to fine-tune the DNA damage response. However, when IMPDH2 is restricted to the nucleus, it depletes nuclear NAD+, leading to PARP1 cleavage and cell death. Our study identifies a non-canonical nuclear role for IMPDH2, acting as a convergence point of nuclear metabolism and DNA damage response., The authors would like to thank the Genomics Unit at the CRG for assistance with the sequencing, the CRG Proteomics Facility (Barcelona, Spain) for the chromatome MS analysis, the CRG Flow Cytometry Facility (Barcelona, Spain) for the cell cycle analysis, Dr. Ivan Perez-Nuñez from Dr. Toni Celià-Terrassa group (IMIM, Barcelona, Spain) for helping with the IHC analysis. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech). We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA program. N.P.L. is supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. L.P.R. is supported by a Fundación Francisco Cobo (Eduardo Gallego) postdoctoral fellowship. The Sdelci lab’s contributions to this study have received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 852343), and from the Spanish Plan Estatal grants (Ministerio de Ciencia e Innovación, PID2019-110598GA-I00/AEI/10.13039/501100011033 and PID2022-141740NB-I00 funded by MICIU /AEI /10.13039/501100011033 / FEDER, UE) and from Fundación BBVA under Beca Leonardo a Investigadores y Creadores Culturales 2022 (LEO22-2-2290-BBM-BAS-167).